Literature DB >> 10641899

Baseline ophthalmic findings in the vitamin E, cataract and age-related maculopathy (VECAT) study.

L D Robman1, G Tikellis, S K Garrett, C A Harper, J J McNeil, H R Taylor, C A McCarty.   

Abstract

PURPOSE: To describe the methodology of eye examination and the baseline eye characteristics of the Vitamin E, Cataract and Age-Related Maculopathy (VECAT) study participants.
METHODS: A sample of volunteers from an urban area of Melbourne, Australia, were recruited to participate in a randomized, controlled trial investigating the effect of vitamin E on the development of cataract and age-related maculopathy Standardized eye examinations involved clinical assessment, which included Wilmer grading of the lens, digital photography of the lens with Nidek EAS-1000 lens camera and stereo photography of the macular area with the Nidek 3-DX fundus camera. All cases of ophthalmic findings were determined on the basis of pathology in the worse eye.
RESULTS: Most eyes were free from abnormalities. The most frequent findings were cataract and age-related macular changes. Nuclear cataract (nuclear opacity grade >2) was present in 4.5%, cortical cataract (cortical opacity grade >2) in 14.3% and posterior subcapsular cataract in 3.0% of participants; in addition, coronary cataract was observed in 13.6%. Soft drusen larger than 125 pm were found in 11.4%, retinal pigment epithelium changes in 9.5%, epiretinal membrane in 6.6% and age-related macular degeneration in 0.5% of participants.
SUMMARY: Due to the selection criteria, the majority of participants had clear or minor lens changes and/or minor retinal age-related changes. Precise instrumental documentation will allow an accurate assessment of the incidence and dynamics of these changes throughout 4 years of observation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10641899     DOI: 10.1046/j.1440-1606.1999.00240.x

Source DB:  PubMed          Journal:  Aust N Z J Ophthalmol        ISSN: 0814-9763


  7 in total

Review 1.  Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.

Authors:  Jennifer R Evans; John G Lawrenson
Journal:  Cochrane Database Syst Rev       Date:  2017-07-31

Review 2.  Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration.

Authors:  Jennifer R Evans; John G Lawrenson
Journal:  Cochrane Database Syst Rev       Date:  2017-07-30

Review 3.  Age-related macular degeneration: epidemiology and optimal treatment.

Authors:  Morten la Cour; Jens Folke Kiilgaard; Mogens Holst Nissen
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

Review 4.  [Lutein and antioxidants in the prevention of age-related macular degeneration].

Authors:  M Rehak; E Fric; P Wiedemann
Journal:  Ophthalmologe       Date:  2008-01       Impact factor: 1.059

5.  Vitamin E supplementation and macular degeneration: randomised controlled trial.

Authors:  Hugh R Taylor; Gabriella Tikellis; Luba D Robman; Catherine A McCarty; John J McNeil
Journal:  BMJ       Date:  2002-07-06

Review 6.  Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases.

Authors:  Goran Bjelakovic; Dimitrinka Nikolova; Lise Lotte Gluud; Rosa G Simonetti; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2012-03-14

7.  Novel measures of cardiovascular health and its association with prevalence and progression of age-related macular degeneration: the CHARM Study.

Authors:  Catherine A McCarty; Adam Dowrick; James Cameron; Barry McGrath; Luba D Robman; Peter Dimitrov; Gabriella Tikellis; Caroline Nicolas; John McNeil; Robyn Guymer
Journal:  BMC Ophthalmol       Date:  2008-12-22       Impact factor: 2.209

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.